Comment
. 2009 Jul 2;361(1):96; author reply 96-7.
Cetuximab for metastatic colorectal cancer
- PMID: 19579281
Item in Clipboard
Comment
Cetuximab for metastatic colorectal cancer
N Engl J Med.
.
No abstract available
Comment on
-
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.N Engl J Med. 2009 Apr 2;360(14):1408-17. doi: 10.1056/NEJMoa0805019. N Engl J Med. 2009. PMID: 19339720 Clinical Trial.
Similar articles
-
Targeting EGFR in colorectal cancer.N Engl J Med. 2008 Oct 23;359(17):1834-6. doi: 10.1056/NEJMe0806778. N Engl J Med. 2008. PMID: 18946069 No abstract available.
-
Cetuximab for metastatic colorectal cancer.N Engl J Med. 2009 Jul 2;361(1):95-6; author reply 96-7. N Engl J Med. 2009. PMID: 19579280 No abstract available.
-
Cetuximab for metastatic colorectal cancer.N Engl J Med. 2009 Jul 2;361(1):95; author reply 96-7. N Engl J Med. 2009. PMID: 19579279 No abstract available.
-
Cetuximab in the treatment of patients with colorectal cancer.Expert Opin Biol Ther. 2011 Jul;11(7):937-49. doi: 10.1517/14712598.2011.582464. Epub 2011 May 11. Expert Opin Biol Ther. 2011. PMID: 21557708 Review.
-
[Application of monoclonal antibody in combination with irinotecan in the treatment of colorectal cancer].Zhonghua Zhong Liu Za Zhi. 2006 Oct;28(10):796-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17366800 Review. Chinese. No abstract available.
Cited by
-
Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer.Cancer Cell Int. 2021 Feb 25;21(1):135. doi: 10.1186/s12935-021-01829-8. Cancer Cell Int. 2021. PMID: 33632198 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical